Sean Keohane Sells 2,779 Shares of Cabot (NYSE:CBT) Stock

Posted by George Bondi on Aug 28th, 2026

Cabot Corporation (NYSE:CBT – Get Free Report) CEO Sean Keohane sold 2,779 shares of the firm’s stock in a transaction on Monday, August 24th. The shares were sold at an average price of $85.50, for a total transaction of $237,604.50. Following the completion of the sale, the chief executive officer owned 288,873 shares in the company, valued at $24,698,641.50. The trade was a 0.95% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this hyperlink.

Cabot Stock Performance

Shares of CBT stock opened at $84.58 on Friday. The company has a current ratio of 1.47, a quick ratio of 0.97 and a debt-to-equity ratio of 0.48. The firm has a fifty day moving average price of $87.77 and a 200 day moving average price of $81.18. The company has a market cap of $4.37 billion, a P/E ratio of 23.83, a PEG ratio of 11.11 and a beta of 0.84. Cabot Corporation has a 12 month low of $58.33 and a 12 month high of $94.53.

Cabot (NYSE:CBT – Get Free Report) last posted its quarterly earnings results on Monday, August 3rd. The specialty chemicals company reported $1.67 earnings per share for the quarter, beating analysts’ consensus estimates of $1.66 by $0.01. The company had revenue of $982.00 million for the quarter, compared to analysts’ expectations of $943.16 million. Cabot had a return on equity of 20.29% and a net margin of 5.23%.Cabot’s quarterly revenue was up 6.4% on a year-over-year basis. During the same period last year, the firm earned $1.90 earnings per share. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. Sell-side analysts predict that Cabot Corporation will post 6.35 earnings per share for the current fiscal year.

Cabot Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 11th. Stockholders of record on Friday, August 28th will be given a dividend of $0.4725 per share. This represents a $1.89 annualized dividend and a dividend yield of 2.2%. The ex-dividend date of this dividend is Friday, August 28th. Cabot’s dividend payout ratio (DPR) is 53.24%.

Hedge Funds Weigh In On Cabot

Institutional investors have recently modified their holdings of the business. Torren Management LLC acquired a new stake in Cabot during the 4th quarter worth $26,000. Rothschild Investment LLC increased its stake in Cabot by 170.4% in the fourth quarter. Rothschild Investment LLC now owns 411 shares of the specialty chemicals company’s stock valued at $27,000 after purchasing an additional 259 shares during the period. Northwestern Mutual Wealth Management Co. purchased a new stake in shares of Cabot in the second quarter valued at about $33,000. Global Retirement Partners LLC raised its holdings in shares of Cabot by 1,606.9% in the fourth quarter. Global Retirement Partners LLC now owns 495 shares of the specialty chemicals company’s stock valued at $33,000 after buying an additional 466 shares during the last quarter. Finally, Geneos Wealth Management Inc. boosted its stake in shares of Cabot by 409.0% during the first quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock worth $38,000 after buying an additional 364 shares during the period. 93.18% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of brokerages recently issued reports on CBT. Wall Street Zen raised Cabot from a “hold” rating to a “buy” rating in a report on Sunday, August 9th. UBS Group reduced their price objective on shares of Cabot from $97.00 to $92.00 and set a “neutral” rating for the company in a research report on Wednesday, August 5th. JPMorgan Chase & Co. upped their target price on shares of Cabot from $70.00 to $78.00 and gave the company an “underweight” rating in a report on Friday, August 7th. Truist Financial set a $100.00 target price on shares of Cabot in a research report on Wednesday, August 5th. Finally, Mizuho lifted their price target on shares of Cabot from $80.00 to $90.00 and gave the stock a “neutral” rating in a research note on Thursday, June 25th. Two equities research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Cabot has a consensus rating of “Hold” and a consensus target price of $89.00.

Check Out Our Latest Stock Analysis on CBT

About Cabot

(Get Free Report)

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.